2a1 Search Results


94
MedChemExpress neurons
Neurons, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2a1/Caloxin+2A1/pmc13002923-322-2-11
Average 94 stars, based on 1 article reviews
neurons - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Hycult Biotech c5b 9
MSC exosomes attenuate complement activation and inflammation in TMJ-OA. Immunohistochemical staining for IL-1β + , TNF-⍺ + <t>and</t> <t>C5b-9</t> + cells in ( A ) synovium and ( B ) condylar cartilage. Representative images ( n = 8 TMJs/group). Scale bars: 100–500 μm. Quantification of IL-1β + , TNF-⍺ + and C5b-9 + cells in ( C ) synovium and ( D ) condylar cartilage. The number of cells that stained positive for IL-1β, TNF-⍺ and C5b-9 were counted at 200 × magnification and expressed as the percentages of positively stained cells or positively stained cells per area. E ELISA quantification of C5b-9 in TMJ synovium and condylar cartilage. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001. n = 6–8 TMJs/group
C5b 9, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2a1/C5b-9%2C+Rat%2C+mAb+2A1/pmc12892732-117-45-48
Average 94 stars, based on 1 article reviews
c5b 9 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

92
Novus Biologicals anti c5b 9
MSC exosomes attenuate complement activation and inflammation in TMJ-OA. Immunohistochemical staining for IL-1β + , TNF-⍺ + <t>and</t> <t>C5b-9</t> + cells in ( A ) synovium and ( B ) condylar cartilage. Representative images ( n = 8 TMJs/group). Scale bars: 100–500 μm. Quantification of IL-1β + , TNF-⍺ + and C5b-9 + cells in ( C ) synovium and ( D ) condylar cartilage. The number of cells that stained positive for IL-1β, TNF-⍺ and C5b-9 were counted at 200 × magnification and expressed as the percentages of positively stained cells or positively stained cells per area. E ELISA quantification of C5b-9 in TMJ synovium and condylar cartilage. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001. n = 6–8 TMJs/group
Anti C5b 9, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2a1/C5b-9+Antibody+(2A1)/pmc10810683-132-5-8
Average 92 stars, based on 1 article reviews
anti c5b 9 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

90
Novus Biologicals rabbit anti sult2a1
MSC exosomes attenuate complement activation and inflammation in TMJ-OA. Immunohistochemical staining for IL-1β + , TNF-⍺ + <t>and</t> <t>C5b-9</t> + cells in ( A ) synovium and ( B ) condylar cartilage. Representative images ( n = 8 TMJs/group). Scale bars: 100–500 μm. Quantification of IL-1β + , TNF-⍺ + and C5b-9 + cells in ( C ) synovium and ( D ) condylar cartilage. The number of cells that stained positive for IL-1β, TNF-⍺ and C5b-9 were counted at 200 × magnification and expressed as the percentages of positively stained cells or positively stained cells per area. E ELISA quantification of C5b-9 in TMJ synovium and condylar cartilage. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001. n = 6–8 TMJs/group
Rabbit Anti Sult2a1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2a1/Cytosolic+Sulfotransferase+2A1%2FSULT2A1+Antibody/bio_rxiv__2022__10__31__514433-305-51-53
Average 90 stars, based on 1 article reviews
rabbit anti sult2a1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
MedChemExpress hy p3278a
MSC exosomes attenuate complement activation and inflammation in TMJ-OA. Immunohistochemical staining for IL-1β + , TNF-⍺ + <t>and</t> <t>C5b-9</t> + cells in ( A ) synovium and ( B ) condylar cartilage. Representative images ( n = 8 TMJs/group). Scale bars: 100–500 μm. Quantification of IL-1β + , TNF-⍺ + and C5b-9 + cells in ( C ) synovium and ( D ) condylar cartilage. The number of cells that stained positive for IL-1β, TNF-⍺ and C5b-9 were counted at 200 × magnification and expressed as the percentages of positively stained cells or positively stained cells per area. E ELISA quantification of C5b-9 in TMJ synovium and condylar cartilage. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001. n = 6–8 TMJs/group
Hy P3278a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2a1/Caloxin+2A1/pmc12287320-230-0-1
Average 93 stars, based on 1 article reviews
hy p3278a - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Novus Biologicals anti rpl11
MSC exosomes attenuate complement activation and inflammation in TMJ-OA. Immunohistochemical staining for IL-1β + , TNF-⍺ + <t>and</t> <t>C5b-9</t> + cells in ( A ) synovium and ( B ) condylar cartilage. Representative images ( n = 8 TMJs/group). Scale bars: 100–500 μm. Quantification of IL-1β + , TNF-⍺ + and C5b-9 + cells in ( C ) synovium and ( D ) condylar cartilage. The number of cells that stained positive for IL-1β, TNF-⍺ and C5b-9 were counted at 200 × magnification and expressed as the percentages of positively stained cells or positively stained cells per area. E ELISA quantification of C5b-9 in TMJ synovium and condylar cartilage. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001. n = 6–8 TMJs/group
Anti Rpl11, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2a1/RPL11+Antibody+(2A1)/pm40565276-163-22-23
Average 93 stars, based on 1 article reviews
anti rpl11 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
R&D Systems cat 9058 bt 050
MSC exosomes attenuate complement activation and inflammation in TMJ-OA. Immunohistochemical staining for IL-1β + , TNF-⍺ + <t>and</t> <t>C5b-9</t> + cells in ( A ) synovium and ( B ) condylar cartilage. Representative images ( n = 8 TMJs/group). Scale bars: 100–500 μm. Quantification of IL-1β + , TNF-⍺ + and C5b-9 + cells in ( C ) synovium and ( D ) condylar cartilage. The number of cells that stained positive for IL-1β, TNF-⍺ and C5b-9 were counted at 200 × magnification and expressed as the percentages of positively stained cells or positively stained cells per area. E ELISA quantification of C5b-9 in TMJ synovium and condylar cartilage. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001. n = 6–8 TMJs/group
Cat 9058 Bt 050, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2a1/Recombinant+Human+BTN2A1%2FButyrophilin+2A1+Protein%2C+CF/pm34260935-254-302-300
Average 90 stars, based on 1 article reviews
cat 9058 bt 050 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

92
Novus Biologicals ovol2
Figure 1. <t>OVOL2</t> loss in TNBC promotes sphere formation and tumor initiation. A) Boxplots illustrating the expression levels of OVOL2 obtained from the UALCAN database. B) The expression of OVOL2 in 12 human breast cancer cell lines was determined by RT–qPCR. C) Cell growth was evaluated using a CCK8 assay. Data were analyzed 48 h after transfection. D) The ability of OVOL2-overexpressing cancer cells to induce mammosphere formation was determined by a mammosphere formation assay. The graphs show the sphere numbers compared to those in the control group. E) In vivo tumor formation in mice injected with serial dilutions of MDA-MB-231 cells. p-value determined by Student’s t-test. The data are presented as means ± SD. The symbols *, **, *** and represent p < 0.05, p < 0.01 and p < 0.001, respectively.
Ovol2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2a1/OVOL2+Antibody+(PCRP-OVOL2-2A1)/pm38627980-431-14-16
Average 92 stars, based on 1 article reviews
ovol2 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

93
Proteintech anti sult2a1 rabbit polyclonal antibody
mRNA and protein expression of drug-metabolizing enzymes in MRP2-knockdown HepG2 cells. MRP2 siRNA was transfected into HepG2 cells. The mRNA expression levels of SULTs (A) and UGTs (B) were measured by RT-qPCR 48 hours after transfection. The relative mRNA expression levels, calculated as fold changes compared with the negative control (NC), were determined by the ΔΔC T method using β -actin as the reference gene. For SULT1A, UGT1A, and UGT2B, the primers were designed to amplify regions common to all isoforms, and further details are provided in the . Protein expression of SULT1E1 (C) and <t>SULT2A1</t> (D) was evaluated by Western blotting at 72 hours after transfection. The representative protein bands are shown. The quantified relative protein expression was normalized to the expression of β -actin as the loading control. Data are expressed as mean ± S.D. from 3 independent experiments. ∗ P < .05, ∗∗ P < .01 vs NC (Dunnett’s test). MRP, multidrug resistance–associated protein; NC, negative control; SULT, sulfotransferase; UGT, UDP-glucuronosyltransferase.
Anti Sult2a1 Rabbit Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2a1/SULT2A1+Antibody/pmc12799537-85-40-46
Average 93 stars, based on 1 article reviews
anti sult2a1 rabbit polyclonal antibody - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Novus Biologicals anti ralbp1
mRNA and protein expression of drug-metabolizing enzymes in MRP2-knockdown HepG2 cells. MRP2 siRNA was transfected into HepG2 cells. The mRNA expression levels of SULTs (A) and UGTs (B) were measured by RT-qPCR 48 hours after transfection. The relative mRNA expression levels, calculated as fold changes compared with the negative control (NC), were determined by the ΔΔC T method using β -actin as the reference gene. For SULT1A, UGT1A, and UGT2B, the primers were designed to amplify regions common to all isoforms, and further details are provided in the . Protein expression of SULT1E1 (C) and <t>SULT2A1</t> (D) was evaluated by Western blotting at 72 hours after transfection. The representative protein bands are shown. The quantified relative protein expression was normalized to the expression of β -actin as the loading control. Data are expressed as mean ± S.D. from 3 independent experiments. ∗ P < .05, ∗∗ P < .01 vs NC (Dunnett’s test). MRP, multidrug resistance–associated protein; NC, negative control; SULT, sulfotransferase; UGT, UDP-glucuronosyltransferase.
Anti Ralbp1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2a1/RALBP1+Antibody+(2A1)/pmc08186483-375-138-143
Average 90 stars, based on 1 article reviews
anti ralbp1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

86
Thermo Fisher carboxyeosin diacetate succinimidyl ester ceda
mRNA and protein expression of drug-metabolizing enzymes in MRP2-knockdown HepG2 cells. MRP2 siRNA was transfected into HepG2 cells. The mRNA expression levels of SULTs (A) and UGTs (B) were measured by RT-qPCR 48 hours after transfection. The relative mRNA expression levels, calculated as fold changes compared with the negative control (NC), were determined by the ΔΔC T method using β -actin as the reference gene. For SULT1A, UGT1A, and UGT2B, the primers were designed to amplify regions common to all isoforms, and further details are provided in the . Protein expression of SULT1E1 (C) and <t>SULT2A1</t> (D) was evaluated by Western blotting at 72 hours after transfection. The representative protein bands are shown. The quantified relative protein expression was normalized to the expression of β -actin as the loading control. Data are expressed as mean ± S.D. from 3 independent experiments. ∗ P < .05, ∗∗ P < .01 vs NC (Dunnett’s test). MRP, multidrug resistance–associated protein; NC, negative control; SULT, sulfotransferase; UGT, UDP-glucuronosyltransferase.
Carboxyeosin Diacetate Succinimidyl Ester Ceda, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2a1/Caloxin+2A1/pmc06226504-258-6-14
Average 86 stars, based on 1 article reviews
carboxyeosin diacetate succinimidyl ester ceda - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

92
R&D Systems sulfotransferase 2a1 sult2a1
(A, B) Relative expression of androgenic enzymes (HSD3B2 and <t>SULT2A1)</t> and cofactor (CYB5A) within the adrenal cortex from eight reproductive-age (24 to 37 y) and eight postmenopausal (60 to 79 y) women, quantified by double immunofluorescence. Both the CYB5A/HSD3B2 and SULT2A1/total cortical area ratios decrease in postmenopausal women as a result of ZR involution with aging. Total cortical area was measured from the outer edge of HSD3B2 expression to the inner edge of SULT2A1 expression. The box contains the 25th to 75th percentiles, the whiskers mark the 5th and 95th percentiles, and the horizontal line within the box represents the median. *P < 0.01. Pre, premenopausal; Post, postmenopausal.
Sulfotransferase 2a1 Sult2a1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2a1/Cytosolic+Sulfotransferase+2A1%2FSULT2A1+Antibody+(OTI4D7)/pmc06525564-105-41-48
Average 92 stars, based on 1 article reviews
sulfotransferase 2a1 sult2a1 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

Image Search Results


MSC exosomes attenuate complement activation and inflammation in TMJ-OA. Immunohistochemical staining for IL-1β + , TNF-⍺ + and C5b-9 + cells in ( A ) synovium and ( B ) condylar cartilage. Representative images ( n = 8 TMJs/group). Scale bars: 100–500 μm. Quantification of IL-1β + , TNF-⍺ + and C5b-9 + cells in ( C ) synovium and ( D ) condylar cartilage. The number of cells that stained positive for IL-1β, TNF-⍺ and C5b-9 were counted at 200 × magnification and expressed as the percentages of positively stained cells or positively stained cells per area. E ELISA quantification of C5b-9 in TMJ synovium and condylar cartilage. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001. n = 6–8 TMJs/group

Journal: Arthritis Research & Therapy

Article Title: Mesenchymal stem cell exosomes alleviate osteoarthritis by inhibiting complement activation via a CD59-dependent pathway

doi: 10.1186/s13075-026-03730-z

Figure Lengend Snippet: MSC exosomes attenuate complement activation and inflammation in TMJ-OA. Immunohistochemical staining for IL-1β + , TNF-⍺ + and C5b-9 + cells in ( A ) synovium and ( B ) condylar cartilage. Representative images ( n = 8 TMJs/group). Scale bars: 100–500 μm. Quantification of IL-1β + , TNF-⍺ + and C5b-9 + cells in ( C ) synovium and ( D ) condylar cartilage. The number of cells that stained positive for IL-1β, TNF-⍺ and C5b-9 were counted at 200 × magnification and expressed as the percentages of positively stained cells or positively stained cells per area. E ELISA quantification of C5b-9 in TMJ synovium and condylar cartilage. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001. n = 6–8 TMJs/group

Article Snippet: P2 chondrocytes were fixed with 4% paraformaldehyde (Sigma) for 30 min, permeabilized with 0.3% Triton X-100 in PBS for 15 min, and blocked with PBS buffer containing 10% FBS and 0.1% Triton X-100 for 2 h. The cells were then incubated with primary antibodies for C5b-9 (HM3033, 1:100; Hycult Biotech) overnight at 4 °C and MMP13 (ab39012, 1:200; Abcam) for 1 h at room temperature.

Techniques: Activation Assay, Immunohistochemical staining, Staining, Enzyme-linked Immunosorbent Assay

MSC exosomes inhibit complement serum-induced C5b-9 formation and MMP13 expression in a dose-dependent manner. A Immunofluorescence staining analysis of C5b-9 (green) and MMP13 (red) on chondrocytes following CS treatment with varying concentrations (1, 5, and 10 µg/ml) of MSC exosomes. Representative images ( n = 4/group). Scale bar: 100 μm. B Quantitative MFI analysis of C5b-9 and MMP13. C ELISA quantification of MMP13 in culture supernatants and ( D ) gene expression analysis of IL-6 and IL-8 following CS treatment with varying concentrations of exosomes. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001, n = 4/group

Journal: Arthritis Research & Therapy

Article Title: Mesenchymal stem cell exosomes alleviate osteoarthritis by inhibiting complement activation via a CD59-dependent pathway

doi: 10.1186/s13075-026-03730-z

Figure Lengend Snippet: MSC exosomes inhibit complement serum-induced C5b-9 formation and MMP13 expression in a dose-dependent manner. A Immunofluorescence staining analysis of C5b-9 (green) and MMP13 (red) on chondrocytes following CS treatment with varying concentrations (1, 5, and 10 µg/ml) of MSC exosomes. Representative images ( n = 4/group). Scale bar: 100 μm. B Quantitative MFI analysis of C5b-9 and MMP13. C ELISA quantification of MMP13 in culture supernatants and ( D ) gene expression analysis of IL-6 and IL-8 following CS treatment with varying concentrations of exosomes. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001, n = 4/group

Article Snippet: P2 chondrocytes were fixed with 4% paraformaldehyde (Sigma) for 30 min, permeabilized with 0.3% Triton X-100 in PBS for 15 min, and blocked with PBS buffer containing 10% FBS and 0.1% Triton X-100 for 2 h. The cells were then incubated with primary antibodies for C5b-9 (HM3033, 1:100; Hycult Biotech) overnight at 4 °C and MMP13 (ab39012, 1:200; Abcam) for 1 h at room temperature.

Techniques: Expressing, Immunofluorescence, Staining, Enzyme-linked Immunosorbent Assay, Gene Expression

Exosomal CD59 mediates the inhibitory effects of MSC exosomes in complement serum-induced C5b-9 formation and MMP13 expression. A Immunofluorescence staining analysis of C5b-9 (green) and MMP13 (red) on chondrocytes following CS treatment with 10 µg/ml exosomes and in the presence or absence of 10 µg/ml anti-CD59 antibody. Representative images ( n = 3/group). Scale bar: 100 μm. B Quantitative MFI analyses of C5b-9 and MMP13. C ELISA quantification of MMP13 in culture supernatants and ( D ) gene expression analysis of IL-6 and IL-8 following CS treatment with MSC exosomes and anti-CD59 antibody. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001, n = 4/group

Journal: Arthritis Research & Therapy

Article Title: Mesenchymal stem cell exosomes alleviate osteoarthritis by inhibiting complement activation via a CD59-dependent pathway

doi: 10.1186/s13075-026-03730-z

Figure Lengend Snippet: Exosomal CD59 mediates the inhibitory effects of MSC exosomes in complement serum-induced C5b-9 formation and MMP13 expression. A Immunofluorescence staining analysis of C5b-9 (green) and MMP13 (red) on chondrocytes following CS treatment with 10 µg/ml exosomes and in the presence or absence of 10 µg/ml anti-CD59 antibody. Representative images ( n = 3/group). Scale bar: 100 μm. B Quantitative MFI analyses of C5b-9 and MMP13. C ELISA quantification of MMP13 in culture supernatants and ( D ) gene expression analysis of IL-6 and IL-8 following CS treatment with MSC exosomes and anti-CD59 antibody. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001, n = 4/group

Article Snippet: P2 chondrocytes were fixed with 4% paraformaldehyde (Sigma) for 30 min, permeabilized with 0.3% Triton X-100 in PBS for 15 min, and blocked with PBS buffer containing 10% FBS and 0.1% Triton X-100 for 2 h. The cells were then incubated with primary antibodies for C5b-9 (HM3033, 1:100; Hycult Biotech) overnight at 4 °C and MMP13 (ab39012, 1:200; Abcam) for 1 h at room temperature.

Techniques: Expressing, Immunofluorescence, Staining, Enzyme-linked Immunosorbent Assay, Gene Expression

Figure 1. OVOL2 loss in TNBC promotes sphere formation and tumor initiation. A) Boxplots illustrating the expression levels of OVOL2 obtained from the UALCAN database. B) The expression of OVOL2 in 12 human breast cancer cell lines was determined by RT–qPCR. C) Cell growth was evaluated using a CCK8 assay. Data were analyzed 48 h after transfection. D) The ability of OVOL2-overexpressing cancer cells to induce mammosphere formation was determined by a mammosphere formation assay. The graphs show the sphere numbers compared to those in the control group. E) In vivo tumor formation in mice injected with serial dilutions of MDA-MB-231 cells. p-value determined by Student’s t-test. The data are presented as means ± SD. The symbols *, **, *** and represent p < 0.05, p < 0.01 and p < 0.001, respectively.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Article Title: Loss of OVOL2 in Triple-Negative Breast Cancer Promotes Fatty Acid Oxidation Fueling Stemness Characteristics.

doi: 10.1002/advs.202308945

Figure Lengend Snippet: Figure 1. OVOL2 loss in TNBC promotes sphere formation and tumor initiation. A) Boxplots illustrating the expression levels of OVOL2 obtained from the UALCAN database. B) The expression of OVOL2 in 12 human breast cancer cell lines was determined by RT–qPCR. C) Cell growth was evaluated using a CCK8 assay. Data were analyzed 48 h after transfection. D) The ability of OVOL2-overexpressing cancer cells to induce mammosphere formation was determined by a mammosphere formation assay. The graphs show the sphere numbers compared to those in the control group. E) In vivo tumor formation in mice injected with serial dilutions of MDA-MB-231 cells. p-value determined by Student’s t-test. The data are presented as means ± SD. The symbols *, **, *** and represent p < 0.05, p < 0.01 and p < 0.001, respectively.

Article Snippet: A second immunoprecipitation reaction was then carried out using antibodies against HDAC1(1:200, Abcam) and OVOL2 (1:100, Novus).

Techniques: Expressing, Quantitative RT-PCR, CCK-8 Assay, Transfection, Tube Formation Assay, Control, In Vivo, Injection

Figure 6. Loss of OVOL2 promotes breast tumor initiation via JAK/STAT3/CPT1 regulated FAO in MMTV-PyVT mice. A) Breeding scheme illustration. B) Kaplan-Meier plots showing mammary tumor-free survival in female PyVT-OVOL2WT (n = 41) and PyVT-OVOL2KO (n = 54) mice. C,D) IHC staining of pSTAT3 and CPT1A C), as well as JAK1, JAK2, and TYK2 D) in mammary tumors from female PyVT and PyVT-OVOL2KO mice. The immunoreactive scores (IRSs) were calculated to analyze the IHC images. Representative images are shown, and the scale bars indicate 50 μm. E) Increased FAO-OCR in PyVT-OVOL2KO mouse tumor cells (n = 5–6) indicating loss of OVOL2 function. FAO-OCR measurements were conducted in primary cultured tumor cells isolated from PyVT mammary tumors after the second passage. F) Elevated ATP levels in PyVT-OVOL2KO mouse tumor cells (n = 9) due to loss of OVOL2. G) Mammosphere formation assay performed on primary cells isolated from PyVT mammary tumors after the second passage and treated with ETO. H) Schematic representation of the procedures for the first and second orthotopic injections. I,J) Enhanced tumor-initiating ability was observed in PyVT-OVOL2KO mouse tumor cells during the first and second orthotopic injections (n = 10–12 mice per group) compared to normal tumor cells. The data are presented as means ± SEM. Statistical significance is represented as ** (p < 0.01), *** (p < 0.001), **** (p < 0.0001), ns (not significant), determined by the Gehan-Breslow-Wilcoxon test.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Article Title: Loss of OVOL2 in Triple-Negative Breast Cancer Promotes Fatty Acid Oxidation Fueling Stemness Characteristics.

doi: 10.1002/advs.202308945

Figure Lengend Snippet: Figure 6. Loss of OVOL2 promotes breast tumor initiation via JAK/STAT3/CPT1 regulated FAO in MMTV-PyVT mice. A) Breeding scheme illustration. B) Kaplan-Meier plots showing mammary tumor-free survival in female PyVT-OVOL2WT (n = 41) and PyVT-OVOL2KO (n = 54) mice. C,D) IHC staining of pSTAT3 and CPT1A C), as well as JAK1, JAK2, and TYK2 D) in mammary tumors from female PyVT and PyVT-OVOL2KO mice. The immunoreactive scores (IRSs) were calculated to analyze the IHC images. Representative images are shown, and the scale bars indicate 50 μm. E) Increased FAO-OCR in PyVT-OVOL2KO mouse tumor cells (n = 5–6) indicating loss of OVOL2 function. FAO-OCR measurements were conducted in primary cultured tumor cells isolated from PyVT mammary tumors after the second passage. F) Elevated ATP levels in PyVT-OVOL2KO mouse tumor cells (n = 9) due to loss of OVOL2. G) Mammosphere formation assay performed on primary cells isolated from PyVT mammary tumors after the second passage and treated with ETO. H) Schematic representation of the procedures for the first and second orthotopic injections. I,J) Enhanced tumor-initiating ability was observed in PyVT-OVOL2KO mouse tumor cells during the first and second orthotopic injections (n = 10–12 mice per group) compared to normal tumor cells. The data are presented as means ± SEM. Statistical significance is represented as ** (p < 0.01), *** (p < 0.001), **** (p < 0.0001), ns (not significant), determined by the Gehan-Breslow-Wilcoxon test.

Article Snippet: A second immunoprecipitation reaction was then carried out using antibodies against HDAC1(1:200, Abcam) and OVOL2 (1:100, Novus).

Techniques: Immunohistochemistry, Cell Culture, Isolation, Tube Formation Assay

Figure 7. Targeting JAK or FAO to inhibit breast tumor progress in OVOL2 knockout mice. A) Experimental schematic for PyVT model mice treated with or without perhexiline (PE, 1 mg kg−1dose by oral gavage three times weekly for three weeks) and subsequent applications in different experiments. B) Survival curves of PyVT and PyVT-OVOL2KO mice treated with or without PE as described. C) A mammosphere formation assay performed on primary cells isolated from PyVT or PyVT-OVOL2KO mice treated with PBS or PE (n = 5–6). D,E) Injection of 1 × 105 PyVT or PyVT-OVOL2KO tumor cells from PyVT model mice treated with or without perhexiline D) or upadacitinib E) into the mammary fat pads of FVB mice. After 21 days, mice were sacrificed, and tumors were collected. F) Schematic illustrating the effect of OVOL2 on breast cancer cells. The data are presented as means ± SEMs. Statistical significance is represented as ** (p < 0.01), *** (p < 0.001), **** (p < 0.0001), ns (not significant), determined by the Gehan–Breslow–Wilcoxon test.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Article Title: Loss of OVOL2 in Triple-Negative Breast Cancer Promotes Fatty Acid Oxidation Fueling Stemness Characteristics.

doi: 10.1002/advs.202308945

Figure Lengend Snippet: Figure 7. Targeting JAK or FAO to inhibit breast tumor progress in OVOL2 knockout mice. A) Experimental schematic for PyVT model mice treated with or without perhexiline (PE, 1 mg kg−1dose by oral gavage three times weekly for three weeks) and subsequent applications in different experiments. B) Survival curves of PyVT and PyVT-OVOL2KO mice treated with or without PE as described. C) A mammosphere formation assay performed on primary cells isolated from PyVT or PyVT-OVOL2KO mice treated with PBS or PE (n = 5–6). D,E) Injection of 1 × 105 PyVT or PyVT-OVOL2KO tumor cells from PyVT model mice treated with or without perhexiline D) or upadacitinib E) into the mammary fat pads of FVB mice. After 21 days, mice were sacrificed, and tumors were collected. F) Schematic illustrating the effect of OVOL2 on breast cancer cells. The data are presented as means ± SEMs. Statistical significance is represented as ** (p < 0.01), *** (p < 0.001), **** (p < 0.0001), ns (not significant), determined by the Gehan–Breslow–Wilcoxon test.

Article Snippet: A second immunoprecipitation reaction was then carried out using antibodies against HDAC1(1:200, Abcam) and OVOL2 (1:100, Novus).

Techniques: Knock-Out, Tube Formation Assay, Isolation, Injection

mRNA and protein expression of drug-metabolizing enzymes in MRP2-knockdown HepG2 cells. MRP2 siRNA was transfected into HepG2 cells. The mRNA expression levels of SULTs (A) and UGTs (B) were measured by RT-qPCR 48 hours after transfection. The relative mRNA expression levels, calculated as fold changes compared with the negative control (NC), were determined by the ΔΔC T method using β -actin as the reference gene. For SULT1A, UGT1A, and UGT2B, the primers were designed to amplify regions common to all isoforms, and further details are provided in the . Protein expression of SULT1E1 (C) and SULT2A1 (D) was evaluated by Western blotting at 72 hours after transfection. The representative protein bands are shown. The quantified relative protein expression was normalized to the expression of β -actin as the loading control. Data are expressed as mean ± S.D. from 3 independent experiments. ∗ P < .05, ∗∗ P < .01 vs NC (Dunnett’s test). MRP, multidrug resistance–associated protein; NC, negative control; SULT, sulfotransferase; UGT, UDP-glucuronosyltransferase.

Journal: Drug Metabolism and Disposition

Article Title: Downregulation of hepatic sulfotransferase 1E1 expression associated with decreased expression of multidrug resistance–associated protein 2

doi: 10.1016/j.dmd.2025.100190

Figure Lengend Snippet: mRNA and protein expression of drug-metabolizing enzymes in MRP2-knockdown HepG2 cells. MRP2 siRNA was transfected into HepG2 cells. The mRNA expression levels of SULTs (A) and UGTs (B) were measured by RT-qPCR 48 hours after transfection. The relative mRNA expression levels, calculated as fold changes compared with the negative control (NC), were determined by the ΔΔC T method using β -actin as the reference gene. For SULT1A, UGT1A, and UGT2B, the primers were designed to amplify regions common to all isoforms, and further details are provided in the . Protein expression of SULT1E1 (C) and SULT2A1 (D) was evaluated by Western blotting at 72 hours after transfection. The representative protein bands are shown. The quantified relative protein expression was normalized to the expression of β -actin as the loading control. Data are expressed as mean ± S.D. from 3 independent experiments. ∗ P < .05, ∗∗ P < .01 vs NC (Dunnett’s test). MRP, multidrug resistance–associated protein; NC, negative control; SULT, sulfotransferase; UGT, UDP-glucuronosyltransferase.

Article Snippet: After transfer to the PVDF membrane and blocking, the membranes were incubated overnight or 2 hours at 4 °C with primary antibodies, anti–MRP2 rabbit polyclonal antibody (1/600; 24893-1-AP; Proteintech Group, Inc), anti-SULT1E1 rabbit polyclonal antibody (1/1000; 12522-1-AP; Proteintech Group, Inc), anti-SULT2A1 rabbit polyclonal antibody (1/1000; 16348-1-AP; Proteintech Group, Inc), and anti– β -actin rabbit polyclonal antibody (1/1,000; PM053; Medical & Biological Laboratories Co, Ltd).

Techniques: Expressing, Knockdown, Transfection, Quantitative RT-PCR, Negative Control, Western Blot, Control

(A, B) Relative expression of androgenic enzymes (HSD3B2 and SULT2A1) and cofactor (CYB5A) within the adrenal cortex from eight reproductive-age (24 to 37 y) and eight postmenopausal (60 to 79 y) women, quantified by double immunofluorescence. Both the CYB5A/HSD3B2 and SULT2A1/total cortical area ratios decrease in postmenopausal women as a result of ZR involution with aging. Total cortical area was measured from the outer edge of HSD3B2 expression to the inner edge of SULT2A1 expression. The box contains the 25th to 75th percentiles, the whiskers mark the 5th and 95th percentiles, and the horizontal line within the box represents the median. *P < 0.01. Pre, premenopausal; Post, postmenopausal.

Journal: The Journal of Clinical Endocrinology and Metabolism

Article Title: 11-Oxygenated C 19 Steroids Do Not Decline With Age in Women

doi: 10.1210/jc.2018-02527

Figure Lengend Snippet: (A, B) Relative expression of androgenic enzymes (HSD3B2 and SULT2A1) and cofactor (CYB5A) within the adrenal cortex from eight reproductive-age (24 to 37 y) and eight postmenopausal (60 to 79 y) women, quantified by double immunofluorescence. Both the CYB5A/HSD3B2 and SULT2A1/total cortical area ratios decrease in postmenopausal women as a result of ZR involution with aging. Total cortical area was measured from the outer edge of HSD3B2 expression to the inner edge of SULT2A1 expression. The box contains the 25th to 75th percentiles, the whiskers mark the 5th and 95th percentiles, and the horizontal line within the box represents the median. *P < 0.01. Pre, premenopausal; Post, postmenopausal.

Article Snippet: We performed double immunofluorescence of 3 β -hydroxysteroid dehydrogenase type 2 (HSD3B2) (anti-human rabbit polyclonal antibody, provided by Dr. C. R. Parker, University of Alabama at Birmingham) and cytochrome b 5 (CYB5A) (anti-human mouse monoclonal antibody; Acris, San Diego, CA), or sulfotransferase 2A1 (SULT2A1) (anti-human mouse monoclonal antibody; R&D Systems Inc., Minneapolis, MN), respectively.

Techniques: Expressing, Immunofluorescence

Representative images for double immunofluorescence of HSD3B2 (red) and CYB5A (green) (A–D) or SULT2A1 (green) (E–H) in the adrenals of a pre- and a postmenopausal woman. In the young adrenal gland, HSD3B2 and CYB5A are segregated to the ZF and ZR, respectively (A, B), whereas the old adrenal demonstrates a thinner ZR and areas with intermingled expression of HSD3B2 and CYB5A (C, D). SULT2A1 is expressed in the ZR and lower ZF of both young and old adrenals (F, H), but the total SULT2A1 area is smaller in the old adrenal because of a thinner ZR.

Journal: The Journal of Clinical Endocrinology and Metabolism

Article Title: 11-Oxygenated C 19 Steroids Do Not Decline With Age in Women

doi: 10.1210/jc.2018-02527

Figure Lengend Snippet: Representative images for double immunofluorescence of HSD3B2 (red) and CYB5A (green) (A–D) or SULT2A1 (green) (E–H) in the adrenals of a pre- and a postmenopausal woman. In the young adrenal gland, HSD3B2 and CYB5A are segregated to the ZF and ZR, respectively (A, B), whereas the old adrenal demonstrates a thinner ZR and areas with intermingled expression of HSD3B2 and CYB5A (C, D). SULT2A1 is expressed in the ZR and lower ZF of both young and old adrenals (F, H), but the total SULT2A1 area is smaller in the old adrenal because of a thinner ZR.

Article Snippet: We performed double immunofluorescence of 3 β -hydroxysteroid dehydrogenase type 2 (HSD3B2) (anti-human rabbit polyclonal antibody, provided by Dr. C. R. Parker, University of Alabama at Birmingham) and cytochrome b 5 (CYB5A) (anti-human mouse monoclonal antibody; Acris, San Diego, CA), or sulfotransferase 2A1 (SULT2A1) (anti-human mouse monoclonal antibody; R&D Systems Inc., Minneapolis, MN), respectively.

Techniques: Immunofluorescence, Expressing

Adrenal C19 steroid pathway. The synthesis of C19 steroids requires both HSD3B2 and CYB5A), whereas the synthesis of sulfated steroids occurs via SULT2A1, which competes with HSD3B2 for the same substrates. Segregation of HDS3B2 and CYB5A to separate zones (ZF and ZR, respectively), along with abundant SULT2A1 expression, as observed in young adrenals, favors the synthesis of DHEAS. Conversely, lower SULT2A1 expression and proximity of HSD3B2- and CYB5A-expressing cells, as observed in old adrenals, favor the synthesis of active androgens. CYP11A1, cytochrome P450 cholesterol side-chain cleavage; CYP11B1, 11β-hydroxylase; CYP17A1, 17α-hydroxylase/17,20-lyase; HSD11B2, 11β-hydroxysteroid dehydrogenase, type 2; StAR, steroidogenic acute regulatory protein.

Journal: The Journal of Clinical Endocrinology and Metabolism

Article Title: 11-Oxygenated C 19 Steroids Do Not Decline With Age in Women

doi: 10.1210/jc.2018-02527

Figure Lengend Snippet: Adrenal C19 steroid pathway. The synthesis of C19 steroids requires both HSD3B2 and CYB5A), whereas the synthesis of sulfated steroids occurs via SULT2A1, which competes with HSD3B2 for the same substrates. Segregation of HDS3B2 and CYB5A to separate zones (ZF and ZR, respectively), along with abundant SULT2A1 expression, as observed in young adrenals, favors the synthesis of DHEAS. Conversely, lower SULT2A1 expression and proximity of HSD3B2- and CYB5A-expressing cells, as observed in old adrenals, favor the synthesis of active androgens. CYP11A1, cytochrome P450 cholesterol side-chain cleavage; CYP11B1, 11β-hydroxylase; CYP17A1, 17α-hydroxylase/17,20-lyase; HSD11B2, 11β-hydroxysteroid dehydrogenase, type 2; StAR, steroidogenic acute regulatory protein.

Article Snippet: We performed double immunofluorescence of 3 β -hydroxysteroid dehydrogenase type 2 (HSD3B2) (anti-human rabbit polyclonal antibody, provided by Dr. C. R. Parker, University of Alabama at Birmingham) and cytochrome b 5 (CYB5A) (anti-human mouse monoclonal antibody; Acris, San Diego, CA), or sulfotransferase 2A1 (SULT2A1) (anti-human mouse monoclonal antibody; R&D Systems Inc., Minneapolis, MN), respectively.

Techniques: Expressing